Bolus Administration of Zidovudine During Pregnancy
This paper does not directly address the question of bolus tocolytic therapy. It examines the relative advantages of continuous intravenous infusion vs bolus oral administration of zidovudine (ZDV), previously known as azidothymidine (AZT) in the treatment of the HIV-infected woman during pregnancy. In an attempt to evaluate these two modes of therapy without risk to the mother and the intrauterine patient, we have studied the placental transfer and metabolism of the drug using an in vitro perfusion technique. Schneider and Proegler have used in vitro perfusion to compare bolus and continuous administration of beta-adrenergic antagonists (5).
Unable to display preview. Download preview PDF.
- 2.Liebes L, Mendoza S, Lee JD, Dancis J (1992) Further observations on zidovudine (AZT) transfer and metabolism of human placenta: Estimates of fetal serum concentrations from a perfusion model. (Submitted)Google Scholar
- 3.Lopez-Anaza A, Unadkat JD, Schuman LA, Smith AL (1990) Pharmacokinetics of zidovudine (azidothymindine) 1. Transplacental transfer. J Acquired Immune Deficiency Syndromes 3: 959–964Google Scholar
- 4.O’Sullivan MJ, Boyer P, Scott G, Parks W, Weller S, Blum M R, Balskey J, Gillespie S, Mitchel C, Bryson YT (1992) A phase 1 study of the pharmacokinetics and safety of zidovudine in third trimester HIV-1 infected pregnant women and their infants. Pediat Res 31: 173AGoogle Scholar
- 6.Schuman P, Kauffman R, Crane LR, Philpot D (1990) Pharmacokinetics of zidovudine (ZDV) during pregnancy. Int. Congress on AIDS, San Francisco Abstract F 13. 17Google Scholar